2022
DOI: 10.3389/fimmu.2022.831815
|View full text |Cite
|
Sign up to set email alerts
|

Activation of NLRP3 Inflammasome by Virus-Like Particles of Human Polyomaviruses in Macrophages

Abstract: Viral antigens can activate phagocytes, inducing inflammation, but the mechanisms are barely explored. The aim of this study is to investigate how viral oligomeric proteins of different structures induce inflammatory response in macrophages. Human THP-1 cell line was used to prepare macrophages that were treated with filamentous nucleocapsid-like particles (NLPs) of paramyxoviruses and spherical virus-like particles (VLPs) of human polyomaviruses. The effects of viral proteins on cell viability, pro-inflammato… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 146 publications
(168 reference statements)
0
1
0
Order By: Relevance
“…For example, MCC950 is a direct inhibitor of NLRP3 protein. It was demonstrated in juvenile mice that after administration of MCC950 in 3 days after IAV infection, the activation of NLRP3 inflammasome was inhibited, which reduced IL-18 secretion into alveolar space and improved the survival of these mice ( Lučiūnaitė et al., 2022 ). Moreover, it was able to reduce lung injury in IAV-induced COPD rats, thereby improving survival time ( Ji et al., 2022 ).…”
Section: Clinical Therapies Targeting the Inflammasomementioning
confidence: 99%
“…For example, MCC950 is a direct inhibitor of NLRP3 protein. It was demonstrated in juvenile mice that after administration of MCC950 in 3 days after IAV infection, the activation of NLRP3 inflammasome was inhibited, which reduced IL-18 secretion into alveolar space and improved the survival of these mice ( Lučiūnaitė et al., 2022 ). Moreover, it was able to reduce lung injury in IAV-induced COPD rats, thereby improving survival time ( Ji et al., 2022 ).…”
Section: Clinical Therapies Targeting the Inflammasomementioning
confidence: 99%